{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:20:27Z","timestamp":1773710427251,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1016\/s0305-7372(03)00003-3","type":"journal-article","created":{"date-parts":[[2003,3,25]],"date-time":"2003-03-25T21:13:35Z","timestamp":1048626815000},"page":"297-307","source":"Crossref","is-referenced-by-count":453,"title":["Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies"],"prefix":"10.1016","volume":"29","author":[{"given":"Aoife M","family":"Shannon","sequence":"first","affiliation":[]},{"given":"David J","family":"Bouchier-Hayes","sequence":"additional","affiliation":[]},{"given":"Claire M","family":"Condron","sequence":"additional","affiliation":[]},{"given":"Deirdre","family":"Toomey","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0305-7372(03)00003-3_BIB1","unstructured":"Berne RM, Levy MN. Transport of oxygen and carbon dioxide: tissue oxygenation. Physiology, 3rd edn., Missouri: Mosby-Year Book Inc, 1993; 590\u2013598"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB2","unstructured":"Ganong WF. Gas transport between the lungs and the tissues. Review of Medical Physiology, 19th edn. Stanford: Appleton and Lange, 1999; 635\u2013639"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumour Hypoxia: definitions and current clinical, biological, and molecular aspects","volume":"93","author":"H\u00f6ckel","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia \u2013 a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MO:18:4:243","article-title":"Treatment resistance of solid tumours: role of hypoxia and anemia","volume":"18","author":"Vaupel","year":"2001","journal-title":"Med. Oncol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB6","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0959-8049(00)00159-3","article-title":"Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation","volume":"36","author":"Dachs","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/gyno.1993.1262","article-title":"Tumour oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix","volume":"52","author":"H\u00f6ckel","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB8","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumours and influences both angiogenesis and tumour growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterisation of hypoxia-inducible factor-1","volume":"1","author":"Wang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB11","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor-1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB12","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"Dimerization, DNA binding, and transactivation properties of HIF-1","volume":"271","author":"Jiang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB13","doi-asserted-by":"crossref","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","article-title":"Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions","volume":"272","author":"Salceda","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF-\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakola","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB17","doi-asserted-by":"crossref","first-page":"32252","DOI":"10.1074\/jbc.271.50.32253","article-title":"Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its \u03b1 subunit","volume":"271","author":"Huang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB18","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor-1\u03b1 is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB19","doi-asserted-by":"crossref","first-page":"18019","DOI":"10.1074\/jbc.273.29.18019","article-title":"Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) is a non-heme iron protein. Implications for oxygen sensing","volume":"273","author":"Srinivas","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB20","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M202487200","article-title":"Hypoxia-inducible factor-1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis","volume":"277","author":"Lu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB21","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1073\/pnas.88.13.5680","article-title":"Hypoxia-inducible nuclear factors bind to an enhancer element located 3\u2032 to the human erythropoietin gene","volume":"88","author":"Semenza","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB22","doi-asserted-by":"crossref","first-page":"21513","DOI":"10.1016\/S0021-9258(20)80571-7","article-title":"Characterization of hypoxia-inducible factor-1 and regulation of DNA binding activity by hypoxia","volume":"269","author":"Wang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB24","doi-asserted-by":"crossref","first-page":"25492","DOI":"10.1074\/jbc.271.41.25492","article-title":"Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein","volume":"271","author":"Levy","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3 Pt 1","key":"10.1016\/S0305-7372(03)00003-3_BIB25","doi-asserted-by":"crossref","first-page":"C682","DOI":"10.1152\/ajpcell.1992.262.3.C682","article-title":"Regulation of glucose transport and GLUT1 glucose transporter expression by O2 in muscle cells in culture","volume":"262","author":"Bashan","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB26","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1128\/MCB.14.9.6264","article-title":"Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status","volume":"14","author":"Graeber","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB27","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V90.9.3322","article-title":"Giaccia Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-Kinase\/Akt signalling pathway in Ha-Ras-transformed cells through a hypoxia inducible factor-1 transcriptional element","volume":"90","author":"Mazure","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB28","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1074\/jbc.272.18.12236","article-title":"Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine","volume":"272","author":"Melillo","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB29","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB30","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1\u03b1 is required for solid tumour formation and embryonic vascularisation","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB31","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor-1\u03b1 in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB32","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumours: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB33","first-page":"666","article-title":"Hypoxia and disease: opportunities for novel diagnostic and therapeutic prodrug strategies","volume":"264","author":"Airley","year":"2000","journal-title":"The Pharm. J."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB34","first-page":"5863","article-title":"The hypoxic cell: a target for selective cancer therapy \u2013 Eighteenth Bruce F. Cain Memorial Award Lecture","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumour angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1073\/pnas.92.3.768","article-title":"Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumour angiogenesis","volume":"92","author":"Shweiki","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1054\/bjoc.2001.1876","article-title":"Vascular endothelial growth factor (VEGF) up regulates Bcl-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells","volume":"85","author":"Pidgeon","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB38","first-page":"374","article-title":"Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo","volume":"71","author":"Minchenko","year":"1994","journal-title":"Lab. Invest."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB39","doi-asserted-by":"crossref","first-page":"19761","DOI":"10.1074\/jbc.270.34.19761","article-title":"Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells","volume":"270","author":"Ikeda","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2613.1998.00088.x","article-title":"Hypoxia-mediated regulation of gene expression in mammalian cells","volume":"79","author":"Shih","year":"1998","journal-title":"Int. J. Exp. Path."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/mp.51.2.55","article-title":"Response of tumour cells to hypoxia: role of p53 and NFkB","volume":"51","author":"Royds","year":"1998","journal-title":"Mol. Pathol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1098\/rstb.1994.0106","article-title":"The role of the p53 protein in the apoptotic response","volume":"345","author":"Lane","year":"1994","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/32925","article-title":"Stabilization of wild-type p53 by hypoxia-inducible factor-1\u03b1","volume":"392","author":"An","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB45","first-page":"4200","article-title":"Selection of human cervical epithelial cells that possess reduced apoptotic potential to low oxygen conditions","volume":"57","author":"Kim","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB46","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/cncr.10520","article-title":"Hypoxia up regulates Bcl-2 expression and suppresses interferon-\u03b3 induced anti-angiogenic activity in human tumour derived endothelial cells","volume":"94","author":"Wang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB48","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/MCB.18.5.2845","article-title":"Regulation of proliferation-survival decisions during tumour cell hypoxia","volume":"18","author":"Schmaltz","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/nbm.1940070305","article-title":"Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi","volume":"7","author":"Vaupel","year":"1994","journal-title":"NMR Biomed."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm0297-177","article-title":"Interstitial pH and pO2 gradients in solid tumours in vivo high-resolution measurements reveal a lack of correlation","volume":"3","author":"Helmlinger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.bi.64.070195.002111","article-title":"Human carbonic anhydrases and carbonic anhydrase deficiencies","volume":"64","author":"Sly","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB52","first-page":"7075","article-title":"Hypoxia-inducible expression of associated\u2013associated carbonic anhydrase IX, in invasive breast carcinoma","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB53","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br. J. Radiol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB54","first-page":"73","article-title":"Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumour cells","volume":"41","author":"Teicher","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB55","unstructured":"Laurence DR, Bennett PN, Brown MJ. Neoplastic disease and immunosuppression. Clinical Pharmacology 8 edn., New York: Churchill Livingstone, 1997; 545\u2013563"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00689633","article-title":"Hypoxia and drug-resistance","volume":"13","author":"Teicher","year":"1994","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB57","first-page":"513","article-title":"Approaches to defining the mechanism of enhancement by Fluosol-DA20% with carbogen of melphalan anti-tumour activity","volume":"47","author":"Teicher","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-1218(84)90122-8","article-title":"Inhibition of the genotoxicity of bleomycin by superoxide dismutase","volume":"135","author":"Cunningham","year":"1984","journal-title":"Mutat. Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB59","first-page":"120","article-title":"DNA damage as a basis for 4\u2032-dimethylepipodophyllotoxin-9- (4,6-O-ethylidene-\u03b2-d-glucopyranoside) (etoposide) cytotoxicity","volume":"43","author":"Wozniak","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB60","first-page":"626","article-title":"Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents","volume":"44","author":"Wozniak","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2184.1991.tb01144.x","article-title":"Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage","volume":"244","author":"Amellem","year":"1991","journal-title":"Cell Prolif."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB62","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1074\/jbc.M010189200","article-title":"Hypoxia inhibits G1\/S transition through regulation of p27 expression","volume":"276","author":"Gardner","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB63","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/MCB.21.4.1196-1206.2001","article-title":"p21 (Cip 1) and p27 (Kip1) regulate cell cycle reentry after hypoxic stressbut are not necessary for hypoxia-induced arrest","volume":"21","author":"Green","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB64","series-title":"Pharmacology","first-page":"670","author":"Rang","year":"1999"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB65","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1093\/nar\/22.23.4884","article-title":"A role for the human DNA-repair enzyme HAP1 in cellular-protection against DNA-damaging agents and hypoxic stress","volume":"22","author":"Walker","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB66","first-page":"5808","article-title":"Metallothionein IIA is up regulated by hypoxia in human A431 squamous carcinoma cells","volume":"53","author":"Murphy","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB67","first-page":"1995","article-title":"Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer","volume":"60","author":"Ebert","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB68","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0306-3623(96)00081-X","article-title":"The P-glycoprotein multidrug transporter","volume":"27","author":"Fardel","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB69","first-page":"1301","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene in human cancers","volume":"1","author":"Nooter","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB70","doi-asserted-by":"crossref","first-page":"9261","DOI":"10.1073\/pnas.84.24.9261","article-title":"Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance","volume":"84","author":"Rice","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB71","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.2451290","article-title":"Cell and environment interactions in tumour microregions, the multicell spheroid model","volume":"248","author":"Sutherland","year":"1988","journal-title":"Science"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB73","first-page":"4921","article-title":"Response of aerobic and hypoxic cells in a solid tumour to adriamycin and cyclophosphamide and interaction of the drugs with radiation","volume":"42","author":"Tannock","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB74","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnci\/81.2.146","article-title":"Distribution and activity of antineoplastic drugs in a tumour model","volume":"81","author":"Durand","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB75","first-page":"3339","article-title":"Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumour subpopulation in vivo in the FSaIIC murine fibrosarcoma","volume":"50","author":"Teicher","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-2952(77)90306-9","article-title":"Transport and binding of daunorubicin, Adriamycin and rubidazole in Ehrlich ascites tumour cells","volume":"26","author":"Skovsgaard","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB77","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bjc.1993.220","article-title":"SR 4233 (tirapazamine): A new anticancer drug exploiting hypoxia in solid tumours","volume":"67","author":"Brown","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB78","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/bjc.1996.187","article-title":"Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro","volume":"73","author":"Siim","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB79","first-page":"4473","article-title":"Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation","volume":"52","author":"Wang","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB80","first-page":"5425","article-title":"Inhibition of DNA replication by Tirapazamine","volume":"61","author":"Peters","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB81","first-page":"5248","article-title":"Tirapazamine: a hypoxia-activated topoisomerase II poison","volume":"62","author":"Peters","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2001.19.2.535","article-title":"Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer","volume":"19","author":"Rischin","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB83","first-page":"3524","article-title":"Survival benefits from tirazone (tirapazamine) and cisplatin in advanced non-small lung cancer (NSCLC) patients: final results from the international Phase III CATAPULT1 trial","volume":"16","author":"Von Pawel","year":"1998","journal-title":"Proc. Natl. Acad. Soc. Clin. Oncol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB84","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1200\/JCO.2000.18.6.1351","article-title":"Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and tirapazamine in subjects with advanced previously untreated non-small-cell lung tumours","volume":"18","author":"von Pawel","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB85","first-page":"4316","article-title":"Identification of small molecule inhibitors of hypoxia-inducible factor-1 transcriptional activation pathway","volume":"62","author":"Rapisarda","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB86","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/82146","article-title":"Suppression of tumour growth through disruption of hypoxia-inducible transcription","volume":"6","author":"Kung","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB87","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.gt.3301388","article-title":"Gene transfer of antisense hypoxia-inducible factor-1\u03b1 enhances the therapeutic efficacy of cancer immunotherapy","volume":"8","author":"Sun","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB88","first-page":"313","article-title":"Targeting gene therapy to cancer: a review","volume":"9","author":"Dachs","year":"1997","journal-title":"Oncol. Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB89","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB90","first-page":"166","article-title":"Tumour infiltrating cells in human cancer. On the possible role of CD16+ macrophages in anti-tumour cytotoxicity","volume":"67","author":"Van Ravensway","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB91","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/bjc.1978.252","article-title":"Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors","volume":"38","author":"Stephens","year":"1978","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB92","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjc.6690158","article-title":"Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast","volume":"79","author":"Leek","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB93","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jlb.63.6.758","article-title":"Hypoxia down-regulates MCP-1 expression: omplications for macrophage distribution in tumours","volume":"63","author":"Negus","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung carcinoma","volume":"79","author":"O\u2019Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB95","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1073\/pnas.95.10.5579","article-title":"Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD","volume":"95","author":"Claesson-Welsh","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.gt.3301058","article-title":"The macrophage \u2013 a novel system to deliver gene therapy to pathological hypoxia","volume":"7","author":"Griffiths","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB97","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","article-title":"Erythropoietin","volume":"77","author":"Krantz","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB98","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1101\/gad.10.2.154","article-title":"Differentiatial effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis","volume":"10","author":"Lin","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB99","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.1992.72.2.449","article-title":"Erythropoietin: structure, control of production, and function","volume":"72","author":"Jelkmann","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB100","first-page":"724","article-title":"Biology of erythropoietin","volume":"83","author":"Lacombe","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB101","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood.V77.2.271.271","article-title":"Erythropoietin mRNA levels are governed by both the rate of gene transcription and post-transcriptional events","volume":"77","author":"Goldberg","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB102","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood.V81.9.2223.2223","article-title":"Structure, function, and activation of the erythropoietin receptor","volume":"81","author":"Youssoufian","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB103","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/1043-4666(93)90047-9","article-title":"The hematopoietin receptor superfamily","volume":"5","author":"Cosman","year":"1993","journal-title":"Cytokine"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00001622-200007000-00004","article-title":"Clinical benefit from erythropoietin","volume":"12","author":"Dicato","year":"2000","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB105","first-page":"4728","article-title":"Blood flow, oxygenation, and bioenergetic status of tumours after erythropoietin treatment in normal and anemic rats","volume":"56","author":"Kelleher","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/003655101316911369","article-title":"Erythropoietin treatment can increase 2,3-diphosphoglycerate levels in red blood cells","volume":"61","author":"Birgegard","year":"2001","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB107","first-page":"1358","article-title":"Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumours","volume":"61","author":"Thews","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB108","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/gyno.1999.5368","article-title":"Effects of recombinant human erythropoietin on the anti-tumour effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect","volume":"73","author":"Silver","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"Suppl 1","key":"10.1016\/S0305-7372(03)00003-3_BIB109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/bjoc.2001.1746","article-title":"Development and characterization of novel erythropoiesis stimulating protein (NESP)","volume":"84","author":"Egrie","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1021\/js950156a","article-title":"Partitioning of ifosfamide and its metabolites between red blood cells and plasma","volume":"85","author":"Momerency","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB111","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.081275298","article-title":"Erythropoietin induces tumour regression and anti-tumour immune responses in murine myeloma models","volume":"98","author":"Mittelman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB112","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1755.2000.00211.x","article-title":"Erythropoietin stimulates proliferation of human renal carcinoma cells","volume":"58","author":"Westenfelder","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB113","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s100249900103","article-title":"Immunohistochemical localization of erythropoietin and its receptor in the developing human brain","volume":"2","author":"Juul","year":"1999","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB114","first-page":"660","article-title":"Origin and fate of erythropoietin in human milk","volume":"48","author":"Juul","year":"2000","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB115","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.1074\/jbc.273.39.25381","article-title":"Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis","volume":"273","author":"Yasuda","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB116","first-page":"3561","article-title":"Erythropoietin and erythropoietin receptor expression in human cancer","volume":"61","author":"Acs","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB117","first-page":"85","article-title":"Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients","volume":"16","author":"del Peso","year":"2000","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/ctrv.1999.0158","article-title":"Tumour vasculature as a target for anticancer therapy","volume":"26","author":"Eatock","year":"2000","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB119","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/bies.10043","article-title":"Vascular endothelial growth factor, a survival factor for tumour cells: implications for anti-angiogenic therapy","volume":"24","author":"Harmey","year":"2002","journal-title":"BioEssays"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB120","first-page":"5565","article-title":"Anti-vascular endothelial growth factor treatment augments tumour radiation response under normoxic or hypoxic conditions","volume":"60","author":"Lee","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB121","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1038\/sj.onc.1204102","article-title":"From oncogene to drug: development of small tyrosine kinase inhibitors as anti-tumour and anti-angiogenic agents","volume":"19","author":"Morin","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB122","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1359-6446(01)01809-8","article-title":"Clinical efforts to modulate angiogenesis in the adult: Gene therapy versus conventional approaches","volume":"6","author":"Liau","year":"2001","journal-title":"Drug Disc. Today"},{"key":"10.1016\/S0305-7372(03)00003-3_BIB123","first-page":"97","article-title":"Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis","volume":"237","author":"Dvorak","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/S0305-7372(03)00003-3_BIB124","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.96.6.3137","article-title":"Enhancement of fluid filtration across tumour vessels: implication for delivery of macromolecules","volume":"96","author":"Netti","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737203000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737203000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T23:14:18Z","timestamp":1622934858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737203000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0305737203000033"],"URL":"https:\/\/doi.org\/10.1016\/s0305-7372(03)00003-3","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}